9 Companies Using Artificial Intelligence to Fight Infectious Diseases

Development of a novel drug is a tedious process that requires immense investments of resources and time—on average, it takes from 8-10 years and capitalized R&D costs are reported between ~$1.1B median and ~$2.2B+ per asset in large-pharma cohorts for a new medicine to complete the journey from initial discovery …

How To Be Ready For Future Pandemics?

What do antibiotic-resistant bacteria (“superbugs”) and coronaviruses have in common? They both can kill lots of people globally, and they both have been commercially unattractive targets for the pharma business for too long.